Why Aurora Cannabis (TSX:ACB) Stock Slumped Over 50% Last Month

Aurora’s less-than-impressive results and tepid outlook sent the stock lower by 51% in September 2020.

| More on:
edit Cannabis leaves of a plant on a dark background

Image source: Getty Images

Shares of marijuana giant Aurora Cannabis (TSX:ACB)(NYSE:ACB) fell over 50% in September 2020. The stock is currently trading at $6.25, which is 92% below its 52-week high.

Aurora Cannabis continues to burn massive wealth and has been one of the worst-performing stocks among pot peers. Let’s take a look at what drove the stock’s recent decline.

Poor quarterly results

Aurora Cannabis announced its fiscal fourth quarter of 2020 results last week and reported net sales of $72.1 million — a decline of 5% compared to Q3 of fiscal 2020. Aurora’s sales were also lower than analyst estimates of $79.6 million.

Further, Aurora forecast cannabis sales between $60 million and $64 million for Q1 of 2021. This represents a sequential decline between 5.3% and 11.2%. Investors were unimpressed about Aurora’s consecutive quarters of revenue decline, resulting in a 30% drop in stock price on September 23.

Aurora Cannabis also reported an EBITDA loss of $34.6 million, which was lower than its loss of $50.4 million in Q3. While the company’s loss narrowed, Aurora has previously targeted achieving a positive EBITDA by Q1 of 2021. This forecast has now been pushed to the second quarter.

Aurora’s stock decline in September could have been worse, as it gained 15% a day before its quarterly results due to an analyst upgrade. Jeffries analyst Owen Bennett upgraded Aurora from “underperform” to “hold” but slashed its 12-month price target by 40% to US$6.53

Further, Bennett expects Aurora Cannabis to face liquidity challenges due to negative profitability, which will mean the company will have to raise additional capital and dilute shareholder wealth yet again.

A tough road ahead for Aurora Cannabis and investors

Last year, Aurora Cannabis had 15 production facilities, which meant it could grow 600,000 kg of cannabis per year at peak capacity. This gave it access to two dozen international markets, and investors thought the company would benefit from economies of scale and international expansion.

However, in 2020, the pot behemoth has shut five small facilities and sold a one-million-square-foot facility to cut costs and lower cash burn.

In the June quarter, Aurora Cannabis reported a staggering $1.6 billion in goodwill impairment charges due to overvalued acquisitions it made in the last few years. At the end of September 2019, the company’s goodwill was $3.7 billion and has since declined to $928 million, still accounting for 33% of total assets.

Another matter for concern is Aurora’s shareholder dilution. As it remains difficult for loss-making companies to raise debt, Aurora has relied on selling equity to raise capital. After accounting for its reverse stock split, Aurora’s share count rose a massive 80-fold from 1.3 million shares in 2014.

The Foolish takeaway

There are several fundamental issues surrounding Aurora stock. It is a loss-making company that is also struggling with falling revenue. Aurora is losing market share and is now repositioning itself in the Canadian consumer market by focusing on premium products, which will also boost profit margins.

However, its glaring unprofitability, weak balance sheet, and the threat of further shareholder dilution will continue to impact the stock in the near term.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned.

More on Cannabis Stocks

Coworkers standing near a wall
Cannabis Stocks

Why Is Everyone Talking About Canopy Growth Stock?

Canopy Growth stock (TSX:WEED) saw shares surge in the last two weeks for a variety of reasons investors can dig…

Read more »

Pot stocks are a riskier investment
Stocks for Beginners

Why Shares of Cannabis Stocks Are Rising This Week

Cannabis stocks received a boost this week as the White House urged the drug enforcement administration to reschedule the drug.

Read more »

A person holds a small glass jar of marijuana.
Stocks for Beginners

Why Canopy Growth Stock Jumped 16% on Wednesday

Canopy Growth stock (TSX:WEED) is up 16% on Wednesday, adding to a surge of 60% growth in the last week…

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »